Liquid biopsy in Cancer Management

Integrating Diagnostics and Clinical Applications
Erscheinungsjahr 2025
ISBN: 978-0-443-27496-1
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 191 mm x 235 mm

Liquid biopsy in Cancer Management: Integrating Diagnostics and Clinical Applications provides a comprehensive overview of liquid biopsy, covering its fundamental principles, technological advancements, clinical applications, and future prospects. In 16 chapters, the book focuses both on the practical implications of liquid biopsy in cancer management, and on its role in early detection, treatment monitoring, and personalized therapy. It emphasizes the integration of liquid biopsy into both diagnostic practices and therapeutic strategies, highlighting its potential to transform cancer care. The book discusses the latest research findings and explores future directions in liquid biopsy research, providing readers with a forward-looking view of the field.

It includes case studies and examples to illustrate the clinical utility of liquid biopsy and enhance understanding of its applications. Overall, the book aims to be a comprehensive and authoritative resource on the subject, providing readers with a thorough understanding of the current state and future directions of liquid biopsy in cancer management.

Autoren/Hrsg.

Bhatt, Shvetank

Chenchula, Santenna

Fachgebiete

• Naturwissenschaften Biowissenschaften Biowissenschaften

Inhaltsverzeichnis

1. Introduction to Liquid biopsy
2. Liquid biopsy current techniques
3. Liquid biopsy in Breast Cancer
4. Liquid biopsy in cervical cancer
5. Liquid biopsy in lung cancer
6. Liquid biopsy in hepatic cancer
7. Liquid biopsy in pancreatic cancer
8. Liquid biopsy in prostate cancer
9. Liquid biopsy in ovarian cancer
10. Liquid biopsy in gastric cancer
11. Liquid biopsy in bone cancer
12. Liquid biopsy in skin cancer
13. Challenges and Limitations of Liquid Biopsy in Precision Oncology
14. Applications of translational Oncology of liquid biopsy
15. Current evidence of Liquid biopsy and its Perspectives on Clinical Advances and Emerging Approaches
16. Liquid Biopsy and Artificial Intelligence as Tools to Detect Colorectal cancer

Über Autor(innen)

Bhatt, Shvetank
Dr. Shvetank Bhatt is an accomplished Associate Professor in the School of Health Sciences and Technology at Dr. Vishwanath Karad MIT World Peace University, located in Pune, Maharashtra, India. He holds an M. Pharm degree in Pharmacology from Manipal College of Pharmaceutical Sciences, MAHE, Manipal, Karnataka, and a Ph.D. in Neuropharmacology from Birla Institute of Technology & Science (BITS) Pilani, Pilani Campus, Rajasthan. With many years of industrial and academic research experience, Dr. Bhatt specializes in CNS disorders, pain, inflammation, and immuno-oncology. He has received numerous accolades, including the Prof. Duggirala Visweswaram & Prof. Sreemantalu Satyanarayana Award for Best Paper in Pharmacology-IJPER in 2012 and 2014. Dr. Bhatt has published dozens of papers in various national and international journals. Dr. Bhatt is a life member of the Association of Pharmaceutical Teachers of India (APTI) and the Indian Pharmacological Society (IPS).

Chenchula, Santenna
Dr. Santenna Chenchula has been an academic faculty member and researcher in the Department of Pharmacology at the All India Institute of Medical Sciences (AIIMS) Bhopal. His research interests span across clinical pharmacology, with a focus on molecular medicine, precision medicine, pharmacogenomics, oncology, rational drug use, antimicrobial resistance, vaccines, drug discovery, clinical trials, and pharmacovigilance. He serves as a reviewer for several national and international journals in the field of biomedical research. To date, he has published dozens of articles in international and national journals and has authored several books as the corresponding first author. He is an active member of the Pharmacogenomics Research Network (PGRN), The American Society for Clinical Pharmacology and Therapeutics (ASCPT), and the Global Center for Evidence Synthesis (GCES). Currently, he is pursuing a PhD in clinical pharmacology, specializing in Precision Medicine and Pharmacogenomics.